Sunshine Biopharma Equity Warrant Exp 15 Feb 2027 SBFMW:NASDAQ

RT Quote | USD
Last | 05/13/24 EDT
0.17quote price arrow up+0.0297 (+21.1689%)
Volume
18,584
52 week range
0.04 - 0.77
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1403
  • 52 Week High0.77
  • 52 Week High Date06/06/23
  • 52 Week Low0.04
  • 52 Week Low Date03/19/24

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1403
  • 52 Week High0.77
  • 52 Week High Date06/06/23
  • 52 Week Low0.04
  • 52 Week Low Date03/19/24
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.04M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sunshine Biopharma Equity Warrant Exp 15 Feb 2027

 

Profile

MORE
Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has 27 additional generic prescription drugs. In addition, the Company is engaged in the development of various proprietary drugs, including Adva-27a, K1.1 mRNA and SBFM-PL4. Adva-27a is a small chemotherapy molecule targeting pancreatic cancer. The K1.1 mRNA is developed...
Steve Slilaty
Chairman of the Board, President, Chief Executive Officer
Marc Beaudoin
Chief Operating Officer
Camille Sebaaly
Chief Financial Officer, Secretary
Address
6500 TRANS-CANADA HIGHWAY, 4TH FLOOR
Pointe-claire, QC
H9R 0A5
Canada